ARS Pharmaceuticals, Inc.

SPRY · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.9B · 163 employees
98
SEC Filings
$3.05
Close 2026-11-04
163
Employees

Business Summary

ARS Pharmaceuticals is a biopharmaceutical company focused on the commercialization and development of neffy (EURneffy in the EU/UK), the first FDA and European Commission-approved needle-free intranasal epinephrine product for emergency treatment of Type I allergic reactions, including anaphylaxis. neffy uses a proprietary absorption enhancer called Intravail to deliver epinephrine intranasally at low doses. The company is also advancing a Phase 2b clinical trial for treatment-refractory chronic urticaria. neffy is approved in the U.S., EU, UK, Japan, Australia, and China, with regulatory review pending in Canada.

Latest Stock Quote

SPRY 2026-11-04 $3.05 O:$3.13 H:$3.225 L:$2.995 Vol:2.5M VWAP:$3.069
origin leaf: null

Next Earnings

expected 2027-02-04

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001193125-26-097478EDGAR112K words
2025-03-202024-12-310000950170-25-042320EDGAR111K words
2024-03-212023-12-310000950170-24-034689EDGAR101K words
2023-03-232022-12-310000950170-23-009491EDGAR103K words
2022-03-312021-12-310000950170-22-005202EDGAR83K words
2021-03-292020-12-310001193125-21-098283EDGAR96K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-052026-09-300001193125-26-449778EDGAR81K words
2026-08-132026-06-300001193125-26-349140EDGAR79K words
2025-11-102025-09-300001193125-25-273111EDGAR81K words
2025-08-132025-06-300000950170-25-107618EDGAR77K words
2025-05-142025-03-310000950170-25-070900EDGAR73K words
2024-11-132024-09-300000950170-24-125924EDGAR67K words
2024-08-062024-06-300000950170-24-091776EDGAR68K words
2024-05-092024-03-310000950170-24-056967EDGAR65K words
2023-11-092023-09-300000950170-23-061996EDGAR70K words
2023-08-102023-06-300000950170-23-041310EDGAR69K words
2023-05-152023-03-310000950170-23-021997EDGAR67K words
2022-11-022022-09-300000950170-22-021234EDGAR38K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-050001193125-26-449748EDGAR3K words
2026-08-130001193125-26-349127EDGAR4K words
2026-07-170001193125-26-307773EDGAR1K words
2026-03-090001193125-26-097467EDGAR4K words
2025-11-100001193125-25-273107EDGAR4K words
2025-09-290001193125-25-223228EDGAR73K words
2025-08-280001193125-25-190202EDGAR1K words
2025-08-130000950170-25-107617EDGAR4K words
2025-06-260001193125-25-148922EDGAR1K words
2025-05-140000950170-25-070899EDGAR4K words

98 total filings indexed. 70 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

emergency-treatment-of-type-i-allergic-reactions-and-anaphylaxis chronic-spontaneous-urticaria-(in-development) u.s.-epinephrine-autoinjector-replacement-market eu/uk-epinephrine-market japan-epinephrine-market australia-epinephrine-market china-epinephrine-market intravail-absorption-enhancer-technology fda-approved-intranasal-epinephrine-delivery european-commission/ema-marketing-authorization

Company Identity

CIK0001671858
TickerSPRY
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.ars-pharma.com
Listed2022-11-09

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 6942dc277a3dc351265e2f195844246483241196d7a2387f101ee6570b92327a
parent: fd2b869d049bc7d7cc4fbea36b3c3458d908aba06ff2680091db415295b5b608
content hash: decf7d1f52fd25f13593c88dac01f552d52e8691b8c6e28c42658f232eae323e
signed: 2026-11-16T19:04:53.997Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up SPRY using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on SPRY, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/SPRY (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.